ENTITY

Apimeds Pharmaceuticals US (APUS US)

1
Analysis
Health CareUnited States
Apimeds Pharmaceuticals US, Inc. is a clinical stage biopharmaceutical company. The Company specializes in developing an intradermally administered bee venom-based toxin which exhibits diverse therapeutic effects. Apimeds Pharmaceuticals US operates in the United States.
more
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
  • Unlock research summaries
  • Follow top, independent analysts
  • Receive personalised alerts
  • Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

or
Already have an account? Sign In Now
x